Method for directly producing cardiac precursor cell or myocardial cell from fibroblast

A technology of fibroblasts and cardiac progenitor cells, applied in the field of cardiac progenitor cells and cardiomyocytes, can solve the problems of only producing functional, immature cardiomyocyte-like cells, and unable to maintain the state of cardiac progenitor cells

Inactive Publication Date: 2018-12-21
UNIV OF TSUKUBA +1
View PDF25 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] However, in the aforementioned method of producing cardiac progenitor cells from fibroblasts using transcription factors (Mesp1, Ets2) and various humoral factors, there is a problem that the state of cardiac progenitor cells cannot be maintained and only functional immature cardiomyocytes can be produced. problems with cells

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for directly producing cardiac precursor cell or myocardial cell from fibroblast
  • Method for directly producing cardiac precursor cell or myocardial cell from fibroblast
  • Method for directly producing cardiac precursor cell or myocardial cell from fibroblast

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0147] [Example 1] Production of mouse fetal fibroblasts (MEFs)

[0148] (1) Production of mouse fetal fibroblasts (MEFs)

[0149] Female ICR mice (CLEA Japan, Inc.) from 7 to 10 weeks after birth were compared with Mesp1-GFP transgenic mice (male) (Development 126, 3437-3447 (1999), "MesP1 is expressed in the heartprecursor cells and required for the formation of a single heart tube") to mate. The day when fertilization was confirmed was regarded as day 0 of pregnancy, and fetuses were removed from pregnant ICR mice on day 12 after pregnancy was confirmed. The heart was removed from the fetus, and the heart was projected using fluorescence with an inverted microscope (Olympus Corporation, IX71), and the fetus emitting GFP fluorescence was selected.

[0150] Limbs and 1 / 2-2 / 3 of the head, lungs, liver, kidneys, intestines and other solid organs were removed from the selected fetuses, and were washed with phosphate buffered saline (PBS: phosphate buffered saline) (-) (WAKO co...

Embodiment 2

[0161] [Example 2] Production of induced cardiac progenitor cells and cell culture

[0162] 3.6×10 6 Inoculate Plat-E packaging (Plat-E packaging) cells at a concentration of 3 cells at 37°C / 5% CO 2 Under the condition of standing (the first day).

[0163] On the second day (day2), 27 µL of FuGENE 6 transfection reagent (Promega, E2691) was mixed in 300 µL of Opti-MEM (Gibco, 31985-070). After standing still for 5 minutes, the retroviral plasmid of pMx-Tbx6 (refer to Cell 142, 375-386, August 6, 2010, "Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by Defined Factors") was injected into the above mixture in an amount of 9000ng. Hit vigorously, then let sit at room temperature for 15 minutes. Add the above solution dropwise to the Plat-E cells prepared on the previous day (the first day), at 37°C / 5%CO 2 Conditioned static (transfection).

[0164] After 24 hours (the third day), the culture medium was replaced with Plat-E medium (DMEM / 10%FBS / PSA) (Table ...

Embodiment 3

[0175] [Example 3] Production and cell culture of induced cardiomyocytes by Tbx6, SRF, and Myocd

[0176] (1) Gene introduction method of Tbx6, SRF, and Myocd by retrovirus

[0177] A virus solution was prepared in the same manner as in "Preparation of Induced Cardiac Progenitor Cells" in Example 2. Among them, three genes were introduced in this example. On the first day, Plat-E cells were prepared in three 10 cm tissue culture dishes by the same method as in Example 2. On the next day, 27 μL of FuGENE 6 transfection reagent (Promega, E2691) was mixed in 300 μL of Opti-MEM (Gibco, 31985-070). After standing still for 5 minutes, pMx-Tbx6, pMx-SRF and pMx-Myocd (manufacturing method refer to Cell 142, 375-386, August 6, 2010, "Direct Reprogramming of Fibroblasts into Functional Cardiomyocytes by DefinedFactors") were injected into the above mixture respectively. 9000ng of retroviral plasmid was knocked vigorously, and then left at room temperature for 15 minutes. Add the ab...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a method for deriving a cardiac precursor cell or myocardial cell from a fibroblast. Provided is a method for producing a cardiac precursor cell that comprises introducing one myocardial reprogramming factor into a fibroblast, or a method for producing a myocardial cell that comprises introducing three myocardial reprogramming factors into a fibroblast.

Description

technical field [0001] The present invention relates to a method for producing cardiac progenitor cells and cardiomyocytes from fibroblasts, and fibroblast-derived cardiac progenitor cells and cardiomyocytes produced by the method. Background technique [0002] Heart disease gradually increases with aging, and the incidence of heart failure in men over 80 years old is as high as 14.7%. The heart is composed of cells such as cardiomyocytes and fibroblasts. The cardiomyocytes responsible for the beating function have little or no regenerative ability, so the treatment methods for heart diseases have been limited so far. [0003] So far, it has been discovered that by introducing three myocardial reprogramming factors (Gata4, Mef2c, Tbx5, hereinafter also referred to as GMT), a method for directly producing cardiomyocyte-like cells from fibroblasts without passing through iPS cells (not Patent Document 1). In this method, it was demonstrated that cardiomyocytes can be directl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N15/09C12N5/071C12N5/10
CPCC12N15/09C12N15/52C12N2506/1307C12N5/0657C12N5/0661C12N5/069C12N2510/00C12N2501/60A61P7/04A61P9/00A61P9/06A61P9/10A61P9/14C12N5/10C12N5/0656C12N15/63
Inventor 家田真树贞广威太郎礒见真理五岛直树
Owner UNIV OF TSUKUBA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap